Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...

Sanofi is conducting a Phase 3 clinical trial titled A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult ...

Kiwifruits, rye bread, and certain supplements may help with symptoms of chronic constipation, according to new ...

Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently completed a Phase 2 clinical study ...

Beyond this study population, there are ongoing randomized trials evaluating NBTXR3 for definitive treatment of HNSCC, including a trial for cisplatin-ineligible patients, as well as a planned study ...

Polypills for HFrEF are being tested in RCTs, and if they’re approved, experts want to be ready for their rollout and use.

Ulixacaltamide is a highly selective small molecule T-type calcium channel inhibitor designed to block neuronal bursting in the cerebello-thalamo-cortical circuit linked to tremor activity.

EyePoint faces clinical, commercial hurdles despite DME, AMD progress and solid funding through 2027. Read why EYPT stock is ...

Patient-reported outcomes (PROs) are widely used in oncology clinical trials to capture patients’ own perspectives on ...

A Taiwan trial found a plant-based serum boosted hair density by 25% in eight weeks using growth factors and natural vesicles ...

Many fruits are rich in vitamins, minerals, dietary fiber, and antioxidants. Pectin, a type of soluble fiber found in many fruits (including apples, citrus fruits, and berries) helps lower cholesterol ...